JP2025011178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025011178A5 JP2025011178A5 JP2024174919A JP2024174919A JP2025011178A5 JP 2025011178 A5 JP2025011178 A5 JP 2025011178A5 JP 2024174919 A JP2024174919 A JP 2024174919A JP 2024174919 A JP2024174919 A JP 2024174919A JP 2025011178 A5 JP2025011178 A5 JP 2025011178A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- acid sequence
- antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2013/002272 | 2013-07-31 | ||
| PCT/EP2013/002272 WO2015014376A1 (en) | 2013-07-31 | 2013-07-31 | Diagnosis and therapy of cancer involving cancer stem cells |
| JP2020024949A JP7136822B2 (ja) | 2013-07-31 | 2020-02-18 | 癌幹細胞を含む癌の診断および治療法 |
| JP2022139001A JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139001A Division JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025011178A JP2025011178A (ja) | 2025-01-23 |
| JP2025011178A5 true JP2025011178A5 (https=) | 2025-03-25 |
Family
ID=48914215
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530504A Pending JP2016533738A (ja) | 2013-07-31 | 2014-07-30 | 癌幹細胞を含む癌の診断および治療法 |
| JP2019020349A Active JP6865778B2 (ja) | 2013-07-31 | 2019-02-07 | 癌幹細胞を含む癌の診断および治療法 |
| JP2020024949A Active JP7136822B2 (ja) | 2013-07-31 | 2020-02-18 | 癌幹細胞を含む癌の診断および治療法 |
| JP2022139001A Active JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
| JP2024174919A Pending JP2025011178A (ja) | 2013-07-31 | 2024-10-04 | 癌幹細胞を含む癌の診断および治療法 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530504A Pending JP2016533738A (ja) | 2013-07-31 | 2014-07-30 | 癌幹細胞を含む癌の診断および治療法 |
| JP2019020349A Active JP6865778B2 (ja) | 2013-07-31 | 2019-02-07 | 癌幹細胞を含む癌の診断および治療法 |
| JP2020024949A Active JP7136822B2 (ja) | 2013-07-31 | 2020-02-18 | 癌幹細胞を含む癌の診断および治療法 |
| JP2022139001A Active JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10604568B2 (https=) |
| JP (5) | JP2016533738A (https=) |
| KR (4) | KR102483410B1 (https=) |
| CN (3) | CN113406327B (https=) |
| AR (1) | AR097178A1 (https=) |
| AU (3) | AU2014298505B2 (https=) |
| BR (1) | BR112016002000A2 (https=) |
| CA (1) | CA2919570A1 (https=) |
| DK (1) | DK3027208T3 (https=) |
| ES (2) | ES2807181T3 (https=) |
| HU (1) | HUE050622T2 (https=) |
| IL (4) | IL308523B2 (https=) |
| MX (2) | MX385872B (https=) |
| NZ (1) | NZ716473A (https=) |
| PT (1) | PT3027208T (https=) |
| RU (2) | RU2749867C2 (https=) |
| SG (2) | SG11201600722PA (https=) |
| UA (1) | UA123428C2 (https=) |
| WO (2) | WO2015014376A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202300421T1 (it) | 2009-02-20 | 2024-01-10 | Astellas Pharma Inc | Metodi e composizioni per la diagnosi e il trattamento del cancro |
| EP2404936A1 (en) | 2010-07-06 | 2012-01-11 | Ganymed Pharmaceuticals AG | Cancer therapy using CLDN6 target-directed antibodies in vivo |
| ES2989943T3 (es) | 2011-05-13 | 2024-11-28 | Astellas Pharma Inc | Anticuerpos para el tratamiento de un cáncer que expresa la Claudina 6 |
| ES2702315T3 (es) | 2012-08-24 | 2019-02-28 | Univ California | Anticuerpos y vacunas para su uso en tratar cánceres ROR1 e inhibir metástasis |
| WO2015014376A1 (en) * | 2013-07-31 | 2015-02-05 | Biontech Ag | Diagnosis and therapy of cancer involving cancer stem cells |
| RU2016122041A (ru) | 2013-11-06 | 2017-12-11 | ЭББВИ СТЕМСЕНТРКС ЭлЭлСи | Новые анти-клаудин антитела и способы их применения |
| JP6408134B2 (ja) * | 2015-03-31 | 2018-10-17 | 三菱日立パワーシステムズ株式会社 | 燃焼バーナ及びボイラ |
| WO2016165762A1 (en) * | 2015-04-15 | 2016-10-20 | Ganymed Pharmaceuticals Ag | Drug conjugates comprising antibodies against claudin 18.2 |
| US20180371550A1 (en) * | 2015-07-08 | 2018-12-27 | Children's Hospital Medical Center | Loss of transcriptional fidelity leads to immunotherapy resistance in cancers |
| TWI767915B (zh) | 2016-06-27 | 2022-06-21 | 加州大學董事會 | Ror-1與btk拮抗劑的組合 |
| CN109843327B (zh) | 2016-07-07 | 2022-05-13 | 小利兰·斯坦福大学托管委员会 | 抗体佐剂缀合物 |
| US10947316B2 (en) * | 2017-06-15 | 2021-03-16 | Development Center For Biotechnology | Antibody-drug conjugates containing anti-Globo H antibodies and uses thereof |
| WO2019048040A1 (en) * | 2017-09-06 | 2019-03-14 | Ganymed Pharmaceuticals Gmbh | ANTIBODIES USEFUL IN THE DIAGNOSIS OF CANCER |
| EP3681993B1 (en) | 2017-09-13 | 2026-04-01 | BioNTech SE | Rna replicon for reprogramming somatic cells |
| NO20210351A1 (en) * | 2017-09-18 | 2021-03-18 | Univ California | Claudin6 antibodies and methods of treating cancer |
| NZ762505A (en) | 2017-09-29 | 2026-03-27 | Daiichi Sankyo Co Ltd | Antibody-pyrrolobenzodiazepine derivative conjugate |
| EP3838291A4 (en) * | 2018-08-13 | 2022-05-11 | Cancerstem Tech Inc. | CANCER STEM CELL MARKERS AND ANTI-CANCER STEM CELL PHARMACEUTICALS |
| MA54955A (fr) | 2019-02-15 | 2021-12-22 | Integral Molecular Inc | Anticorps anti-claudine 6 et leurs utilisations |
| WO2020190725A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| DK3941946T3 (da) | 2019-03-20 | 2025-03-24 | Univ California | Claudin-6-antistoffer og lægemiddelkonjugater |
| MX2022000111A (es) | 2019-07-10 | 2022-02-10 | Chugai Pharmaceutical Co Ltd | Moleculas de union a claudina-6 y usos de las mismas. |
| CN111087465B (zh) * | 2019-12-24 | 2020-12-08 | 广州医科大学 | 一种针对密蛋白6的抗体偶联药物及应用 |
| CN113832226B (zh) * | 2020-06-24 | 2023-06-30 | 广州医科大学附属第五医院 | 研究gnl3与肝癌发展的相关性的方法及gnl3作为肝肿瘤干细胞、肝癌标志物的用途 |
| JP2024511277A (ja) | 2021-02-19 | 2024-03-13 | メビオン・メディカル・システムズ・インコーポレーテッド | 粒子線治療システムのためのガントリー |
| TW202430574A (zh) | 2022-11-30 | 2024-08-01 | 美商積分分子股份有限公司 | 針對密連蛋白６之抗體，包括其雙特異性格式 |
| WO2024165057A1 (en) * | 2023-02-07 | 2024-08-15 | LaNova Medicines Limited | Antibodies and antibody-drug conjugates targeting claudin 6 |
| IL324834A (en) | 2023-05-25 | 2026-01-01 | Univ California | Dosage of claudin-6 conjugates for cancer treatment |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| GB9019812D0 (en) | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
| US5830755A (en) | 1995-03-27 | 1998-11-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | T-cell receptors and their use in therapeutic and diagnostic methods |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| WO2000073348A2 (en) | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
| WO2002008284A2 (en) | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| WO2002000690A2 (en) | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| WO2000078961A1 (en) | 1999-06-23 | 2000-12-28 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US5928631A (en) | 1997-06-09 | 1999-07-27 | The Procter & Gamble Company | Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins |
| US20020127584A1 (en) | 1997-09-18 | 2002-09-12 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US5932445A (en) | 1997-11-07 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Signal peptide-containing proteins |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| NZ531664A (en) | 1998-09-01 | 2005-07-29 | Genentech Inc | Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family |
| AU773028B2 (en) | 1998-11-03 | 2004-05-13 | Adherex Technologies Inc. | Compounds and methods for modulating claudin-mediated functions |
| AU3124000A (en) | 1998-12-17 | 2000-07-03 | Human Genome Sciences, Inc. | 47 human secreted proteins |
| JP2002536995A (ja) | 1999-02-22 | 2002-11-05 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 結腸の疾患に関連する遺伝子 |
| EP1514933A1 (en) | 1999-07-08 | 2005-03-16 | Research Association for Biotechnology | Secretory protein or membrane protein |
| CA2402563A1 (en) | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| AU2001236470A1 (en) | 2000-01-14 | 2001-07-24 | Corixa Corporation | Ovarian tumor-associated sequences |
| ES2336887T5 (es) | 2000-03-30 | 2019-03-06 | Whitehead Inst Biomedical Res | Mediadores de interferencia por ARN específicos de secuencias de ARN |
| AU6531101A (en) | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU2001273150A1 (en) | 2000-07-20 | 2002-02-05 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20030100713A1 (en) | 2000-07-25 | 2003-05-29 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EA013564B1 (ru) | 2000-08-03 | 2010-06-30 | Терапеутик Хьюман Поликлоналз Инк. | Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция |
| CA2430013C (en) | 2000-11-30 | 2011-11-22 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| PT2000545E (pt) | 2001-06-20 | 2011-12-21 | Genentech Inc | Composições e métodos para o diagnóstico e tratamento do tumor pulmonar |
| CA2379661A1 (en) | 2002-03-28 | 2003-09-28 | Kursad Turksen | Paracellular drug delivery system |
| JP2005536190A (ja) | 2002-04-16 | 2005-12-02 | ジェネンテック・インコーポレーテッド | 腫瘍の診断と治療のための組成物と方法 |
| US20070207142A1 (en) * | 2002-05-08 | 2007-09-06 | Genentech, Inc. | Compositions and methods for the treatment of tumor of hematopoietic origin |
| AU2003295328A1 (en) | 2002-10-02 | 2004-04-23 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| BRPI0315295C1 (pt) | 2002-10-17 | 2021-05-25 | Genmab As | anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão |
| AU2003303144A1 (en) | 2002-10-18 | 2004-07-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| AT500651B9 (de) | 2003-05-27 | 2010-04-15 | Altropus Gmbh | Aktiv immunisierender antikörper |
| US20050031615A1 (en) | 2003-05-30 | 2005-02-10 | Anderson G. Mark | Method of inhibiting tumor growth with anti-tissue factor antibodies |
| US20060019256A1 (en) * | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2006033664A1 (en) | 2004-03-08 | 2006-03-30 | Avalon Pharmaceuticals | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| US7431927B2 (en) | 2005-03-24 | 2008-10-07 | Epitomics, Inc. | TNFα-neutralizing antibodies |
| DE102005025041A1 (de) | 2005-05-30 | 2006-12-07 | Bell Flavors & Fragrances Duft Und Aroma Gmbh | Mittel zur Anwendung in Spülmaschinen sowie Vorrichtung für dessen dosierte Einbringung während der Spül- und Trocknungsphasen |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| EP2368908A3 (en) * | 2006-11-10 | 2011-10-12 | CovX Technologies Ireland Limited | Anti- angiogenic compounds |
| JPWO2008114733A1 (ja) | 2007-03-16 | 2010-07-01 | 協和発酵キリン株式会社 | 抗Ｃｌａｕｄｉｎ−４抗体 |
| EP1997832A1 (en) | 2007-05-29 | 2008-12-03 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against Claudin-18 for treatment of cancer |
| WO2009025759A1 (en) | 2007-08-17 | 2009-02-26 | Progenics Pharmaceuticals (Nevada), Inc. | Tight junction proteins associated with infection and entry of hepatitis c virus (hcv), methods and uses thereof |
| WO2009028663A1 (ja) | 2007-08-30 | 2009-03-05 | Kyowa Hakko Kirin Co., Ltd. | 抗Claudin-3抗体 |
| EP2060583A1 (en) | 2007-10-23 | 2009-05-20 | Ganymed Pharmaceuticals AG | Identification of tumor-associated markers for diagnosis and therapy |
| EP2241578B1 (en) | 2008-01-11 | 2016-04-20 | The University of Tokyo | Anti-cldn6 antibody |
| WO2009120905A2 (en) * | 2008-03-26 | 2009-10-01 | Cellerant Therapeutics, Inc. | Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof |
| AU2009234259A1 (en) | 2008-04-11 | 2009-10-15 | Bionovo, Inc. | Anticancer methods employing extracts of Gleditsia sinensis Lam |
| US9005963B2 (en) | 2008-10-14 | 2015-04-14 | Ablynx N.V. | Amino acid sequences directed against cellular receptors for viruses and bacteria |
| DE102009026966A1 (de) | 2008-12-18 | 2010-07-01 | Robert Bosch Gmbh | Betrieb eines Bremskraftverstärkers als Pedalsimulator |
| JP2010178650A (ja) | 2009-02-04 | 2010-08-19 | Univ Of Tokyo | 固形癌の再発予測のための試験方法および再発予防剤 |
| EP2221063A1 (en) | 2009-02-20 | 2010-08-25 | Ganymed Pharmaceuticals AG | Methods and compositions for diagnosis and treatment of cancer |
| SMT202300421T1 (it) | 2009-02-20 | 2024-01-10 | Astellas Pharma Inc | Metodi e composizioni per la diagnosi e il trattamento del cancro |
| EP2322555A1 (en) * | 2009-11-11 | 2011-05-18 | Ganymed Pharmaceuticals AG | Antibodies specific for claudin 6 (CLDN6) |
| DK3305813T3 (da) | 2009-11-11 | 2020-04-20 | Astellas Pharma Inc | Antistoffer, der er specifikke for claudin 6 (cldn6) |
| WO2011105551A1 (ja) | 2010-02-26 | 2011-09-01 | 国立大学法人大阪大学 | 癌幹細胞の検出方法、及び癌の治療剤または再発予防剤 |
| JP2011213612A (ja) * | 2010-03-31 | 2011-10-27 | Kyowa Hakko Kirin Co Ltd | 癌幹細胞及び／または癌前駆細胞の減少剤 |
| EP2404936A1 (en) | 2010-07-06 | 2012-01-11 | Ganymed Pharmaceuticals AG | Cancer therapy using CLDN6 target-directed antibodies in vivo |
| ES2989943T3 (es) | 2011-05-13 | 2024-11-28 | Astellas Pharma Inc | Anticuerpos para el tratamiento de un cáncer que expresa la Claudina 6 |
| EP2749641B1 (en) | 2011-09-07 | 2021-06-02 | Chugai Seiyaku Kabushiki Kaisha | Cancer stem cell isolation |
| EP2605017A1 (de) | 2011-12-16 | 2013-06-19 | Protagen AG | Markersequenzen für gynäkologisches Malignom und deren Verwendung |
| KR101242726B1 (ko) | 2012-01-26 | 2013-03-13 | 한국과학기술원 | 종양줄기세포 특성 암의 진단 및 치료제 |
| EP2875046B2 (en) | 2012-07-19 | 2025-04-30 | Amgen Inc. | Human btnl3 proteins, nucleic acids, and antibodies and uses thereof |
| JP6499079B2 (ja) * | 2012-11-13 | 2019-04-10 | バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ | クローディンを発現するガン疾患を処置するための剤 |
| WO2014075697A1 (en) * | 2012-11-13 | 2014-05-22 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases |
| BR112015022855A2 (pt) * | 2013-03-14 | 2017-11-07 | Shire Human Genetic Therapies | composições e método para produção de um anticorpo in vitro |
| WO2015014376A1 (en) * | 2013-07-31 | 2015-02-05 | Biontech Ag | Diagnosis and therapy of cancer involving cancer stem cells |
-
2013
- 2013-07-31 WO PCT/EP2013/002272 patent/WO2015014376A1/en not_active Ceased
-
2014
- 2014-07-29 IL IL308523A patent/IL308523B2/en unknown
- 2014-07-30 CN CN202110621737.5A patent/CN113406327B/zh active Active
- 2014-07-30 KR KR1020217031149A patent/KR102483410B1/ko active Active
- 2014-07-30 MX MX2016001186A patent/MX385872B/es unknown
- 2014-07-30 UA UAA201601865A patent/UA123428C2/uk unknown
- 2014-07-30 KR KR1020227045732A patent/KR102663127B1/ko active Active
- 2014-07-30 NZ NZ716473A patent/NZ716473A/en unknown
- 2014-07-30 IL IL293880A patent/IL293880B2/en unknown
- 2014-07-30 BR BR112016002000A patent/BR112016002000A2/pt not_active Application Discontinuation
- 2014-07-30 PT PT147503312T patent/PT3027208T/pt unknown
- 2014-07-30 HU HUE14750331A patent/HUE050622T2/hu unknown
- 2014-07-30 RU RU2016107005A patent/RU2749867C2/ru active
- 2014-07-30 DK DK14750331.2T patent/DK3027208T3/da active
- 2014-07-30 ES ES14750331T patent/ES2807181T3/es active Active
- 2014-07-30 WO PCT/EP2014/066330 patent/WO2015014870A1/en not_active Ceased
- 2014-07-30 SG SG11201600722PA patent/SG11201600722PA/en unknown
- 2014-07-30 CA CA2919570A patent/CA2919570A1/en active Pending
- 2014-07-30 IL IL243408A patent/IL243408B/en unknown
- 2014-07-30 US US14/904,011 patent/US10604568B2/en active Active
- 2014-07-30 KR KR1020247014359A patent/KR102867808B1/ko active Active
- 2014-07-30 RU RU2020123616A patent/RU2020123616A/ru unknown
- 2014-07-30 AU AU2014298505A patent/AU2014298505B2/en active Active
- 2014-07-30 CN CN201480042769.8A patent/CN105407922B/zh active Active
- 2014-07-30 SG SG10201800834RA patent/SG10201800834RA/en unknown
- 2014-07-30 KR KR1020167005323A patent/KR102308813B1/ko active Active
- 2014-07-30 IL IL310824A patent/IL310824A/en unknown
- 2014-07-30 ES ES20180951T patent/ES3041948T3/es active Active
- 2014-07-30 CN CN202110630292.7A patent/CN113252898A/zh active Pending
- 2014-07-30 JP JP2016530504A patent/JP2016533738A/ja active Pending
- 2014-07-31 AR ARP140102879A patent/AR097178A1/es active IP Right Grant
-
2016
- 2016-01-27 MX MX2021010672A patent/MX2021010672A/es unknown
-
2019
- 2019-02-07 JP JP2019020349A patent/JP6865778B2/ja active Active
-
2020
- 2020-02-18 JP JP2020024949A patent/JP7136822B2/ja active Active
- 2020-02-19 US US16/795,468 patent/US11795218B2/en active Active
- 2020-02-24 AU AU2020201331A patent/AU2020201331B2/en active Active
-
2022
- 2022-07-19 AU AU2022206711A patent/AU2022206711B2/en active Active
- 2022-09-01 JP JP2022139001A patent/JP7611196B2/ja active Active
-
2023
- 2023-06-22 US US18/339,837 patent/US20240059772A1/en active Pending
-
2024
- 2024-10-04 JP JP2024174919A patent/JP2025011178A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025011178A5 (https=) | ||
| JP2021522801A5 (https=) | ||
| JP2021510521A5 (https=) | ||
| JP2021508469A5 (https=) | ||
| JP2021524268A5 (https=) | ||
| JP2019533719A5 (https=) | ||
| JP2020516240A5 (https=) | ||
| RU2019138067A (ru) | Биспецифическое антитело против ox40 и ctla-4 | |
| JP2018518540A5 (https=) | ||
| JP2022530404A5 (https=) | ||
| HRP20160082T1 (hr) | Sastavi i postupci za dijagnosticiranje i lijeäśenje raka | |
| RU2017116020A (ru) | Комбинированная терапия биспецифичными антителами, специфичными к fap и dr5, и химиотерапевтические агенты | |
| FI3941946T3 (fi) | Klaudiini-6-vasta-aineita ja klaudiini-6-vasta-ainelääkekonjugaatteja | |
| JP2021511026A5 (https=) | ||
| JP2017503480A5 (https=) | ||
| JP2013527762A5 (https=) | ||
| JP2024535930A5 (https=) | ||
| JP2023089245A5 (https=) | ||
| JP2022553922A5 (https=) | ||
| JP2025507817A5 (https=) | ||
| JP2021531255A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JP2022512851A5 (https=) | ||
| JP2021512107A5 (https=) | ||
| JP2023530036A5 (https=) |